The FDA did not respond to a request for comment. U.S. Health Secretary Robert F. Kennedy Jr. has said that the agency's ...

With long development timelines and high burn rates, biotech companies must navigate capital markets with precision.

Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and ...

Billy Evans, the partner of imprisoned Theranos founder Elizabeth Holmes, is raising millions of dollars for a new ...

Amid a shaky macroeconomic backdrop, biotech stocks have underperformed, with XBI showing poor technical momentum and ...

Pathos AI has secured $365 million in a series D raise as the artificial-intelligence-powered biotech looks to fund trials of ...

The one-off treatment highlights the promise of a new type of gene editing and the challenges of using it to treat extremely ...

Dr Mary Lynne Hedley, a trailblazer in biotechnology and scientific entrepreneurship, recently visited Cyprus to inspire the ...

Some biotech executives spoke about early-stage testing on condition of anonymity to avoid drawing attention to their companies or risking retribution for criticising the Trump administration.

For many companies, Kendall Square’s status as a global center of biotechnology firms and research ... as the place to be — only enhances the draw. Kendall is a place where Cambridge used ...